Abstract
Maesa lanceolata is an ethno-medicinal plant distributed in Central and East Africa, especially Ethiopia and Kenya. It has been used as a traditional medicine against bacterial infections in the small intestine and viral infections in the liver and throat, as well as treatment for rheumatic arthritis. Even though the activity of M. lanceolata leaves has been studied in angiogenesis, which is significantly related to cancer and tumorigenesis, tangible evidence for cancer inhibiting activity of M. lanceolata seeds has not yet been obtained. To the best of our knowledge, this is the first study in which an anti-cancer compound has been identified from the seeds of M. lanceolata and its anti-tumor activity evaluated in HCT116 human colon cancer cells.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of the Korean Society for Applied Biological Chemistry
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
